Mengyi Li

机构：National Clinical Research Center for Digestive Diseases, Huazhong University of Science and Technology Hospital, Huazhong University of Science and Technology · ORCID：0000-0002-1950-6752

发表论文 85 篇 · 总被引 765 次 · h-index 16

代表论文

• Effect of hypertension on long-term adverse clinical outcomes and liver fibrosis progression in MASLD (2025 · Journal of Hepatology · 被引 43)
• Fine Particulate Matter, Its Constituents, and Spontaneous Preterm Birth (2024 · JAMA Network Open · 被引 28)
• Longitudinal Changes in Fibrosis Markers: Monitoring Stiffness/Fibrosis Progression and Prognostic Outcomes in MASLD (2025 · Clinical Gastroenterology and Hepatology · 被引 27)
• CD36-mediated uptake of oxidized LDL induces double-negative regulatory T cell ferroptosis in metabolic dysfunction-associated steatotic liver disease (2024 · Metabolism · 被引 22)
• Photoactive metal-covalent organic framework nanozymes with enhanced peroxidase-mimicking activity for eliminating drug-resistant bacterial infections (2025 · Journal of Colloid and Interface Science · 被引 21)
• The direct and indirect inhibition of proinflammatory adipose tissue macrophages by acarbose in diet-induced obesity (2024 · Cell Reports Medicine · 被引 20)